Myeloperoxidase (MPO) by Immunohistochemistry
Also known as: MYELOP IHC
Use
Myeloperoxidase immunohistochemistry (MPO IHC) is used as a myeloid lineage marker to identify myeloid cells—including neutrophils and eosinophils—within tissue specimens, aiding in the evaluation of hematopoietic disorders such as acute leukemias and related proliferative disorders.
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
Myeloperoxidase
Protein
LOINC Codes
- 94736-6 - Tissue block ID Spec
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Min: 2 slides
Container
Tissue transport kit (ARUP supply #47808) or positively charged slides
Collection Instructions
Transport tissue block or 5 unstained (3- to 5‑micron thick sections), positively charged slides. If sending precut slides, do not oven bake.
Storage Instructions
Room temperature or refrigerated; ship in cooled container during summer months.
Causes for Rejection
Specimens submitted with non‑representative tissue type; depleted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant